Joining me in the episode is Cannara Biotech’s CFO, Nicholas Sosiak.
In the episode we talk about:
-
The battle between Suits and Legacy Growers and how the best companies have them working in harmony together (7:20)
-
The problems of having saturated genetics in the market, and how Cannara Biotech is standing out (14:36)
-
How cannabis culture differs in Quebec, and why they were relatively slow to adopt cannabis 2.0 products (17:36)